JG
REGN icon

Jefferies Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Jefferies Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,300
Closed -$14.2M – 1799
2022
Q1 		$14.2M Buy
+20,300
New +$12.8M 0.09% 176
2021
Q1 		– Sell
-10,000
Closed -$4.83M – 1927
2020
Q4 		$4.83M Hold
10,000
– – 0.04% 422
2020
Q3 		$5.6M Hold
10,000
– – 0.06% 258
2020
Q2 		$6.24K Buy
10,000
+3,800
+61% +$2.16M 0.07% 227
2020
Q1 		$3.03M Sell
6,200
-7,200
-54% -$2.97M 0.03% 502
2019
Q4 		$5.03M Buy
13,400
+7,300
+120% +$2.46M 0.04% 513
2019
Q3 		$1.69M Sell
6,100
-7,000
-53% -$2.07M 0.01% 1196
2019
Q2 		$4.1M Buy
+13,100
New +$4.36M 0.03% 562
2018
Q4 		– Sell
-5,600
Closed -$2.26M – 2489
2018
Q3 		$2.26M Buy
5,600
+5,300
+1,767% +$2.02M 0.01% 914
2018
Q2 		$103K Sell
300
-3,100
-91% -$970K ﹤0.01% 2132
2018
Q1 		$1.17M Sell
3,400
-1,000
-23% -$348K 0.01% 1130
2017
Q4 		$1.65M Buy
4,400
+4,000
+1,000% +$1.62M 0.01% 1086
2017
Q3 		$179K Sell
400
-13,000
-97% -$6.19M ﹤0.01% 2094
2017
Q2 		$6.58M Buy
13,400
+11,500
+605% +$5.03M 0.04% 411
2017
Q1 		$736K Buy
1,900
+1,300
+217% +$482K 0.01% 1421
2016
Q4 		$220K Sell
600
-2,700
-82% -$1.03M ﹤0.01% 1880
2016
Q3 		$1.33M Buy
+3,300
New +$1.32M 0.01% 1143

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jefferies Group's REGN Position: Q2 2022 in Review

Jefferies Group sold out of Regeneron Pharmaceuticals (REGN) in Q2 2022, closing a stake of 27,236 shares — an estimated $19M sold.

Jefferies Group first reported a position in REGN in Q2 2013 and held it in 31 quarters. The position peaked at $19M in Q1 2022. 1,063 funds tracked by Wall St. Rank hold REGN as of Q2 2022.

  • Jefferies Group reported no remaining Regeneron Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 27,236 Regeneron Pharmaceuticals shares in Q2 2022, an estimated $19M.
  • Jefferies Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 31 quarters.
  • Jefferies Group's Regeneron Pharmaceuticals position peaked at $19M in Q1 2022.
  • 1,063 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.